Organovo To Present At 28th Annual Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo"), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced that Chairman and Chief Executive Officer Keith Murphy is scheduled to speak at the 28 th Annual Piper Jaffray Healthcare Conference in New York on Tuesday, November 29 th at 4:00 p.m. Eastern Time (ET).  The presentation will be simultaneously audio webcast at http://www.organovo.com.  The audio webcast will be archived for 90 days following the conference.

About Organovo Holdings, Inc.Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications.  The Company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic and other partners.  Organovo's 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost.  The Company's ExVive Human Liver and Kidney Tissues are used in toxicology and other preclinical drug testing.  The Company also actively conducts early research on specific tissues for therapeutic use in direct surgical applications.  In addition to numerous scientific publications, the Company's technology has been featured in The Wall Street Journal, Time Magazine, The Economist, Forbes, and numerous other media outlets.  Organovo is changing the shape of life science research and transforming medical care.  Learn more at  www.organovo.com.
Investor Contact:		Steve Kunszabo	Organovo Holdings, Inc.+1 (858) 224-1092 skunszabo@organovo.com Press Contact:Jessica YinglingLittle Dog Communications+1 (858) 480-2411jessica@litldog.com  

Primary Logo

If you liked this article you might like

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

These Biotech Stocks are BOOMING

These Biotech Stocks are BOOMING

Biotech Movers: Shire, Bellicum, Organovo

Biotech Movers: Shire, Bellicum, Organovo

Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda

Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda

Biotech Movers: Organovo, Endo, Omeros

Biotech Movers: Organovo, Endo, Omeros